UNICREDIT BANK GMBH | Market Closed - Boerse Frankfurt Warrants 01:39:20 2024-06-04 pm EDT | ||
| 458.8 EUR | -0.40% |
|
| Current month | +0.84% | ||
| 1 month | +0.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 458.8 | -0.40% |
| 24-06-03 | 460.7 | +1.24% |
| 24-05-31 | 455 | +0.12% |
| 24-05-30 | 454.5 | +4.21% |
| 24-05-29 | 436.1 | -2.70% |
Real-time Boerse Frankfurt Warrants
Last update June 04, 2024 at 01:39 pm EDT
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
UniCredit
|
| WKN | HVB3UE |
| ISIN | DE000HVB3UE7 |
| Date issued | 2019-10-08 |
| Strike | 62.28 € |
| Maturity | 2024-10-04 (122 Days) |
| Parity | 0.06 : 1 |
| Emission price | 1,000 € |
| Emission volume | N/A |
| Settlement | both |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1,137 € |
|---|---|
| Lowest since issue | 410.9 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.34
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.30%
- Stock Market
- Certificates
- Certificat
